123-I ioflupane (Datscan®) presynaptic nigrostriatal imaging in patients with movement disorders
123-I Ioflupane (Datscan®) presynaptic imaging has been shown to have a significant utility in the assessment of patients with movement disorders 123-I Ioflupane SPECT is able to distinguish between Parkinson’s disease (PD) and other forms of parkinsonism without degeneration of the nigrostriatal pa...
Main Authors: | Angel Soriano Castrejón, Ana María García Vicente, Montserrat Cortés Romera, Julia Vaamonde Cano, Sonia Rodado Marina, Victor Manuel Poblete García, Sebastián Ruiz Solís, María del Prado Talavera Rubio |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto de Tecnologia do Paraná (Tecpar)
2005-10-01
|
Series: | Brazilian Archives of Biology and Technology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700017 |
Similar Items
-
Interpreting 123I–ioflupane dopamine transporter scans using hybrid scores
by: Kenneth J. Nichols, et al.
Published: (2018-05-01) -
Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of 123I-Ioflupane SPECT: an investigation of parkinsonian syndromes
by: Yu Iwabuchi, et al.
Published: (2019-09-01) -
Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
by: Hidetomo Murakami, et al.
Published: (2017-09-01) -
Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of 123I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
by: Hidetomo Murakami, et al.
Published: (2018-12-01) -
Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings
by: Yu Iwabuchi, et al.
Published: (2019-01-01)